|
1
|
Runowicz CD, Leach CR, Henry NL, Henry KS,
Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge
SB, Jacobs LA, et al: American Cancer Society/American Society of
clinical oncology breast cancer survivorship care guideline. J Clin
Oncol. 34:611–635. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hong W and Dong E: The past, present and
future of breast cancer research in China. Cancer Lett. 351:1–5.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Z, Sun L, Zhang Y, Lu G, Li Y and
Wei Z: Long non-coding RNA FEZF1-AS1 promotes breast cancer
stemness and tumorigenesis via targeting miR-30a/Nanog axis. J Cell
Physiol. 2018. View Article : Google Scholar
|
|
4
|
Sun Y, Zeng C, Gan S, Li H, Cheng Y, Chen
D, Li R and Zhu W: LncRNA HOTTIP-mediated HOXA11 expression
promotes cell growth, migration and inhibits cell apoptosis in
breast cancer. Int J Mol Sci. 19:E4722018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Y, Jiang B, Wu X, Huang Q, Chen W, Zhu
H, Qu X, Xie L, Ma X and Huang G: Long non-coding RNA MIAT is
estrogen-responsive and promotes estrogen-induced proliferation in
ER-positive breast cancer cells. Biochem Biophys Res Commun.
S0006-291X(18)31215-4. 2018.
|
|
6
|
Shi D and Zhang Y, Lu R and Zhang Y: The
long non-coding RNA MALAT1 interacted with miR-218 modulates
choriocarcinoma growth by targeting Fbxw8. Biomed Pharmacother.
97:543–550. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ye B, Liu B, Yang L, Zhu X, Zhang D, Wu W,
Zhu P, Wang Y, Wang S, Xia P, et al: LncKdm2b controls self-renewal
of embryonic stem cells via activating expression of transcription
factor Zbtb3. EMBO J. 37:e971742018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Caldwell KK, Hafez A, Solomon E,
Cunningham M and Allan AM: Arsenic exposure during embryonic
development alters the expression of the long noncoding RNA growth
arrest specific-5 (Gas5) in a sex-dependent manner. Neurotoxicol
Teratol. 66:102–112. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu B, Ye B, Yang L, Zhu X, Huang G, Zhu
P, Du Y, Wu J, Qin X, Chen R, et al: Long noncoding RNA lncKdm2b is
required for ILC3 maintenance by initiation of Zfp292 expression.
Nat Immunol. 18:499–508. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu P, Wang Y, Wu J, Huang G, Liu B, Ye B,
Du Y, Gao G, Tian Y, He L and Fan Z: LncBRM initiates YAP1
signalling activation to drive self-renewal of liver cancer stem
cells. Nat Commun. 7:136082016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo Y, Ouyang J, Zhou D, Zhong S, Wen M,
Ou W, Yu H, Jia L and Huang Y: Long noncoding RNA GAPLINC promotes
cells migration and invasion in colorectal cancer cell by
regulating miR-34a/c-MET signal pathway. Dig Dis Sci. 63:890–899.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen C, Zhou L, Wang H, Chen J, Li W, Liu
W, Shen M, Liu H and Fu X: Long noncoding RNA CNALPTC1 promotes
cell proliferation and migration of papillary thyroid cancer via
sponging miR-30 family. Am J Cancer Res. 8:192–206. 2018.PubMed/NCBI
|
|
13
|
Wang Y, Zhang W, Wang Y and Wang S:
HOXD-AS1 promotes cell proliferation, migration and invasion
through miR-608/FZD4 axis in ovarian cancer. Am J Cancer Res.
8:170–182. 2018.PubMed/NCBI
|
|
14
|
Pan L, Liang W, Gu J, Zang X, Huang Z, Shi
H, Chen J, Fu M, Zhang P, Xiao X, et al: Long noncoding RNA DANCR
is activated by SALL4 and promotes the proliferation and invasion
of gastric cancer cells. Oncotarget. 9:1915–1930. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang R, Wu JC, Zheng LM, Li ZR, Zhou KL,
Zhang ZS, Xu DF and Chen C: Long noncoding RNA RUSC1-AS-N indicates
poor prognosis and increases cell viability in hepatocellular
carcinoma. Eur Rev Med Pharmacol Sci. 22:388–396. 2018.PubMed/NCBI
|
|
16
|
Zhang XD, Huang GW, Xie YH, He JZ, Guo JC,
Xu XE, Liao LD, Xie YM, Song YM, Li EM and Xu LY: The interaction
of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in
ESCC cells. Nucleic Acids Res. 46:1793–1809. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo X, Qiu Y, Jiang Y, Chen F, Jiang L,
Zhou Y, Dan H, Zeng X, Lei YL and Chen Q: Long non-coding RNA
implicated in the invasion and metastasis of head and neck cancer:
Possible function and mechanisms. Mol Cancer. 17:142018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou S, Wang L, Yang Q, Liu H, Meng Q,
Jiang L, Wang S and Jiang W: Systematical analysis of lncRNA-mRNA
competing endogenous RNA network in breast cancer subtypes. Breast
Cancer Res Treat. 169:267–275. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang YX, Yuan J, Gao ZM and Zhang ZG:
LncRNA TUC338 promotes invasion of lung cancer by activating MAPK
pathway. Eur Rev Med Pharmacol Sci. 22:443–449. 2018.PubMed/NCBI
|
|
21
|
Peng R, Luo C, Guo Q, Cao J, Yang Q, Dong
K, Wang S, Wang K and Song C: Association analyses of genetic
variants in long non-coding RNA MALAT1 with breast cancer
susceptibility and mRNA expression of MALAT1 in Chinese Han
population. Gene. 642:241–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu G, Hu X and Zhou G: Long non-coding
RNA OR3A4 promotes proliferation and migration in breast cancer.
Biomed Pharmacother. 96:426–433. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lai XJ and Cheng HF: LncRNA colon
cancer-associated transcript 1 (CCAT1) promotes proliferation and
metastasis of ovarian cancer via miR-1290. Eur Rev Med Pharmacol
Sci. 22:322–328. 2018.PubMed/NCBI
|
|
24
|
Xu W, He L, Li Y, Tan Y, Zhang F and Xu H:
Silencing of lncRNA ZFAS1 inhibits malignancies by blocking
Wnt/β-catenin signaling in gastric cancer cells. Biosci Biotechnol
Biochem. 82:456–465. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang P, Zhou H, Lu K, Lu Y, Wang Y and
Feng T: Exosome-mediated delivery of MALAT1 induces cell
proliferation in breast cancer. Onco Targets Ther. 11:291–299.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang S, Wang J, Ghoshal T, Wilkins D, Mo
YY, Chen Y and Zhou Y: lncRNA gene signatures for prediction of
breast cancer intrinsic subtypes and prognosis. Genes (Basel).
9:E652018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Z, Hou P, Fan D, Dong M, Ma M, Li H,
Yao R, Li Y, Wang G, Geng P, et al: The degradation of EZH2
mediated by lncRNA ANCR attenuated the invasion and metastasis of
breast cancer. Cell Death Differ. 24:59–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang W, Cui X, Chen J, Feng Y, Song E, Li
J and Liu Y: Long non-coding RNA NKILA inhibits migration and
invasion of tongue squamous cell carcinoma cells via suppressing
epithelial-mesenchymal transition. Oncotarget. 7:62520–62532.
2016.PubMed/NCBI
|
|
29
|
Xu YC, Liang CJ, Zhang DX, Li GQ, Gao X,
Fu JZ, Xia F, Ji JJ, Zhang LJ, Li GM and Wu JX: LncSHRG promotes
hepatocellular carcinoma progression by activating HES6.
Oncotarget. 8:70630–70641. 2017.PubMed/NCBI
|
|
30
|
Shi J, Wang YJ, Sun CR, Qin B, Zhang Y and
Chen G: Long noncoding RNA lncHERG promotes cell proliferation,
migration and invasion in glioblastoma. Oncotarget.
8:108031–108041. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu P, Wang Y, Huang G, Ye B, Liu B, Wu J,
Du Y, He L and Fan Z: lnc-β-Catm elicits EZH2-dependent β-catenin
stabilization and sustains liver CSC self-renewal. Nat Struct Mol
Biol. 23:631–639. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ouyang S, Zheng X, Zhou X, Chen Z, Yang X
and Xie M: LncRNA BCAR4 promotes colon cancer progression via
activating Wnt/β-catenin signaling. Oncotarget. 8:92815–92826.
2017. View Article : Google Scholar : PubMed/NCBI
|
